Xtx Topco LTD Vanda Pharmaceuticals Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$3.91 - $6.5 $51,916 - $86,307	13,278 New	13,278 $75,000
Q4 2023 Feb 13, 2024	SELL	$3.38 - $4.58 $86,494 - $117,202	-25,590 Reduced 40.93%	36,924 $155,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $158,826 - $243,806	37,109 Added 146.07%	62,514 $270,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $3,380 - $3,982	-573 Reduced 2.21%	25,405 $167,000
Q1 2023 May 12, 2023	SELL	$6.18 - $7.99 $128,074 - $165,584	-20,724 Reduced 44.37%	25,978 $176,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $320,842 - $511,853	46,702 New	46,702 $345,000

161

45.3M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $283M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.